Research Article
[Retracted] Potassium Channel Ether à go-go1 Is Aberrantly Expressed in Human Liposarcoma and Promotes Tumorigenesis
Table 2
Clinical Parameters of liposarcoma specimens and Eag1 expression.
| Clinical parameters of samples | Number of tumors (%) | Eag1 expression (%) | value | |
| Sex | | | 0.382 | 0.536 | Male | 33 (41.2%) | 21 (63.6%) | | | Female | 47 (58.8%) | 33 (70.2%) | | | Age (year) | | | 0.166 | 0.983 | ≤30 | 4 (5.0%) | 3 (75.0%) | | | 30–39 | 25 (31.3%) | 17 (68.0%) | | | 40–60 | 34 (42.5%) | 23 (67.6%) | | | >60 | 17 (21.2%) | 11 (64.7%) | | | Site | | | 0.735 | 0.865 | Limbs | 21 (26.2%) | 13 (61.9%) | | | Trunk | 23 (28.8%) | 15 (65.2%) | | | Abdominal cavity | 21 (26.2%) | 15 (71.4%) | | | Other | 15 (18.8%) | 11 (73.3%) | | | Histology | | | 1.19 | 0.755 | Well differentiated | 26 (32.5%) | 19 (73.1%) | | | Myxoid | 22 (27.5%) | 15 (68.2%) | | | Pleomorphic | 13 (16.3%) | 9 (69.2%) | | | Round cell | 19 (23.7%) | 11 (57.9%) | | | Grade | | | 1.605 | 0.205 | Low-grade | 48 (60.0%) | 35 (72.9%) | | | High-grade | 32 (40.0%) | 19 (59.4%) | | | Type | | | 0.214 | 0.644 | Primary | 61 (76.3%) | 42 (68.9%) | | | Recurrence | 19 (23.7%) | 12 (63.2%) | | |
| Total | 80 | 54 (67.5%) | | |
|
|